- ADVERTISEMENT
-
Most Popular
- ADVERTISEMENT
Search Results
240 results for dgse
OCGN Stock: The Big COVAXIN News That Ocugen Bulls Should Watch
OCGN stock bulls should pay close attention to the latest news on the COVAXIN vaccine and on speculative social media chatter.
Minerva Neurosciences: NERV Stock Plummets 72% on Schizophrenia Study
Minerva Neurosciences (NERV) is seeing NERV stock nosedive on Friday after announcing results from a recent schizophrenia study.
Is BioNTech a Buy Ahead of Earnings?
Many biotech companies are working on COVID-19 vaccines, but I believe BioNTech stands to be one of the biggest winners in the months ahead.
ArQule News: ARQL Stock Skyrockets on Blood Cancer Study Results
ArQule (ARQL) stock is skyrocketing more than 30% as the company’s blood cancer drug ARQ 531 has begun showing promise in its early going.
Bristol-Myers’ Near Term Rides on Blood Thinner Study
It’s likely sink-or-swim later this month when results are announced.
Biden Vaccine Rollout Plan Assures Success for Moderna
Moderna stock investors should be glad to know that the government is ordering huge quantities of Covid-19 vaccines from just two companies.
Novavax Stock Is an Underdog You Should Bank On
The development a Covid-19 vaccine is no longer a race to the finish line, but there are still plenty of reasons to buy NVAX stock.
Don’t Count on OTC Lipitor as an Rx for Higher PFE Stock
PFE stock holders are looking forward to cholesterol reducer Lipitor becoming an OTC drug, but Pfizer shareholders may have a long and disappointing wait.
Can Tesla Inc (TSLA) Stock Hold the Line Before Model 3 Launch?
TSLA stock is up against the ropes after several doses of bad news. Tesla CEO Elon Musk is trying to counter by pumping up the…
Novavax Looks Like a Good Stock to Trade
For retail traders seeking short-term profits, NVAX stock is looking interesting once again. However, it’s not a good long-term investment.
While Risks Remain, VBI Vaccines Stock Is a Buy at Today’s Prices
Sci-B-Vac’s success will make or break VBIV stock. But the shares’ recent pullback may have created a great buying opportunity.
Novavax Stock Is on the Way with Ramp up in EUA Filings
NVAX has fallen sharply recently, but the time is ripe to buy this stock and take advantage of near-term catalysts like EUA filings.
Ahead of Positive Catalysts, Novavax Stock Is Attractive on Weakness
The patent waiver matter will likely prove to be a “nonissue,” while NVAX stock has many upcoming, positive catalysts.
Zagfen Obesity Drug Trial Results Send ZFGN Soaring
Zagfen shares were flying high on Wednesday following positive results from a Phase III drug trial of its new obesity drug.
Moderna’s Lot Recall Is a Blot Despite Its Recent 2nd Covid-19 Booster Approval
MRNA stock could get hurt from a recent recall in Moderna’s Covid-19 vaccine, despite other recent good news from an EUA approval.
Monkeypox Stocks GOVX, VRAX, SIGA Rocket on Vaccine Shortage Fears
Monkeypox stocks are rallying today amid worries about a shortage of vaccines for the illness in the United States.
Does Sorrento Therapeutics Meet the ‘SAD’ Criteria for Vaccines?
If you love to gamble, SRNE stock is the right one for you. Few other companies, if any, have pivoted as hard as Sorrento did…
Why This Company’s Covid-19 Vaccine Is Just the Beginning
It’s little surprise that some of the companies behind the Covid-19 vaccines have seen their stocks rise. Here’s how investors can benefit.
Why Kite Pharma Inc (KITE) Stock Is Flying High Today
Kite Pharma (KITE) stock was up today following the release of positive results for its leukemia drug during its Phase 1 trial.
Biogen (BIIB) Stock: Promising Alzheimer’s Drug Could Reap Billions
Biogen Idec (BIIB) stock rallied today after an early-stage Alzheimer’s drug slowed mental declines rapidly. The potential market is too large to ignore.
OCGN Stock Alert: Why Is Ocugen Soaring 10% Today?
Shares of OCGN stock are in the green after Covaxin demonstrated strong protection against the omicron and delta variants.
NVAX Stock: The Huge Vaccine News Helping Novavax Shoot Higher Today
Novavax reported positive results from its long-awaited Covid-19 vaccine trials. With G7 leaders promising more vaccines for poorer countries, NVAX could be a beneficiary.
BNTX Stock Alert: The Omicron Vaccine News That Has BioNTech Shooting Higher Today
BioNTech (BNTX) stock is rising higher on news it and Pfizer (PFE) can test a new Covid-19 vaccine for Omicron in adults.
8 – 10 of 240 results
